Press release

With Multix Impact Siemens Healthineers improves both access to high-quality X-ray imaging and patient experience

RSNA 2018 in Chicago: South Hall, Booth #4136

Published on November 26, 2018

Multix Impact is pending 510(k) clearance, and not yet commercially available in the United States and other countries.

Multix Impact is not commercially available in all countries. Its future availability cannot be guaranteed. Further details are available from the local Siemens Healthineers organizations.

Siemens Healthineers 2018

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of €13.4 billion and adjusted profit of €2.3 billion and has about 50,000 employees worldwide.